Sur vs Turkmenistan: New cases tested for RR-/MDR-TB
Sur
97.0%
in 2024
Turkmenistan
100.0%
in 2022
Sur rank
2nd
Turkmenistan rank
1st
New cases tested for RR-/MDR-TB over time
- Sur
- Turkmenistan
How they compare
Turkmenistan currently reports 100.0% against 97.0% in Sur, a difference of 3.0%.
The two have swapped places 2 times across 7 shared years of data; in 2009 it was Turkmenistan ahead.
Sur ranks 2nd and Turkmenistan ranks 1st of 2 regions.
Across the 3 decades both report, Sur averaged higher in 1 and Turkmenistan in 2.
Head to head by decade
| Decade | Sur | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.7% | 12.0% | 11.3% | Turkmenistan |
| 2010s | 57.6% | 45.0% | 12.6% | Sur |
| 2020s | 97.7% | 100.0% | 2.3% | Turkmenistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Sur or Turkmenistan?
- Turkmenistan, at 100.0% against 97.0% in Sur as of 2022.
- What is the difference in new cases tested for rr-/mdr-tb between Sur and Turkmenistan?
- 3.0%, with Turkmenistan ahead.
- How many years of comparable data are there for Sur and Turkmenistan?
- 7 years are reported by both, from 2009 to 2022.
- How do Sur and Turkmenistan rank globally for new cases tested for rr-/mdr-tb?
- Sur ranks 2nd and Turkmenistan ranks 1st of 2 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.